Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy
- 31 January 2009
- journal article
- Published by Elsevier BV in Brain, Behavior, and Immunity
- Vol. 23 (1), 92-100
- https://doi.org/10.1016/j.bbi.2008.09.004
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Sensory neuron targeting by self-complementary AAV8 via lumbar puncture for chronic painProceedings of the National Academy of Sciences of the United States of America, 2008
- Influence of TRPV1 on Diabetes-Induced Alterations in Thermal Pain SensitivityMolecular Pain, 2008
- The characterization and role of regulatory T cells in immune reactionsFrontiers in Bioscience-Landmark, 2008
- FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitisBrain Research Bulletin, 2007
- Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in ratsBrain, Behavior, and Immunity, 2007
- Symptom Burden in Persons With Spinal Cord InjuryArchives of Physical Medicine and Rehabilitation, 2007
- The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic painNeuron Glia Biology, 2006
- Glial modulation of synaptic transmission in cultureGlia, 2004
- Chemotherapy-evoked Painful Peripheral NeuropathyPain Medicine, 2001
- Interleukin-1β (IL-1β) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitroNeuroscience Letters, 1996